Megacv Duo

# MegaCv duo ## Overview - **Classification**: Penicillin antibiotic combined with a beta-lactamase inhibitor. - **Mechanism**: Amoxicillin inhibits bacterial cell wall synthesis. Clavulanate inhibits beta-lactamase enzymes, protecting amoxicillin from degradation. ## Primary Indications 1. **Acute Otitis Media (AOM)** - Especially for resistant strains or treatment failure. 2. **Acute Bacterial Sinusitis** - For suspected bacterial infections, including pediatric. 3. **Community-Acquired Pneumonia (CAP)** - When resistant pathogens or co-morbidities are present. 4. **Skin and Soft Tissue Infections** - Bites, cellulitis with polymicrobial suspicion. 5. **Urinary Tract Infections (UTI)** - Complicated UTIs or those resistant to first-line agents. ## Adult Dosing ### Standard Dosing **Acute Bacterial Sinusitis / CAP / Bites** - **Dose**: **875 mg / 125 mg** (amoxicillin/clavulanate) - **Frequency**: Every **12 hours** - **Route**: Oral - **Duration**: 7 to 10 days **Mild to Moderate Infections (e.g., Skin/Soft Tissue, less severe AOM)** - **Dose**: **500 mg / 125 mg** (amoxicillin/clavulanate) - **Frequency**: Every **8 hours** - **Route**: Oral - **Duration**: 7 to 10 days ### Dose Adjustments - **Renal Impairment**: - CrCl > 30 mL/min: No adjustment needed. - CrCl 10-30 mL/min: **500 mg / 125 mg** every **12 hours**. - CrCl < 10 mL/min: **500 mg / 125 mg** every **24 hours**. - Hemodialysis: **500 mg / 125 mg** every **24 hours**; administer additional dose after dialysis. - **Hepatic Impairment**: Use with **caution**. Monitor liver function regularly. - **Elderly Patients**: No specific adjustment, but often have reduced renal function; adjust based on CrCl. ## Pediatric Dosing (Doses expressed as amoxicillin component) ### Neonates (0-28 days) - **Dose**: Generally **not recommended** due to risk of gastrointestinal intolerance and potential for high bilirubin levels. - **Special Notes**: Use only if essential for severe infections and no alternatives; consider consultation with ID specialist. ### Infants (1-12 months) - **Indication**: Acute Otitis Media, Sinusitis (higher dose) - **Dose**: **90 mg/kg/day** - **Frequency**: Divided every **12 hours** - **Maximum**: Not to exceed adult dose; consider clavulanate limit (e.g., **10 mg/kg/day**). - **Formulation**: Oral suspension (e.g., 600 mg/42.9 mg per 5 mL). ### Children (1-12 years) - **Indication**: Acute Otitis Media, Sinusitis, CAP (higher dose) - **Dose**: **90 mg/kg/day** (Amoxicillin component) - **Frequency**: Divided every **12 hours** - **Maximum**: **2000 mg** amoxicillin per day (equivalent to adult high dose). - **Formulation**: Oral suspension (e.g., 600 mg/42.9 mg per 5 mL) or chewable tablets. - **Indication**: Lower respiratory, Skin/Soft Tissue (lower dose) - **Dose**: **25-45 mg/kg/day** (Amoxicillin component) - **Frequency**: Divided every **12 hours** or **8 hours** - **Maximum**: **1000 mg** amoxicillin per day. ### Adolescents (13-18 years) - **Dose**: Generally follow **adult dosing** recommendations. - **Maximum**: **2000 mg** amoxicillin per day. - **Special Notes**: Consider tablet formulation if able to swallow pills. ## Safety Information ### Contraindications - **Absolute**: History of **severe hypersensitivity** (e.g., anaphylaxis, SJS) to amoxicillin, clavulanate, or other beta-lactams. - **Absolute**: History of **cholestatic jaundice** or **hepatic dysfunction** associated with amoxicillin/clavulanate. ### Common Adverse Effects - **Very Common (>10%)**: Diarrhea, Nausea, Vomiting. - **Common (1-10%)**: Rash, Urticaria, Headache, Vaginitis. - **Serious but Rare**: Clostridioides difficile-associated diarrhea (CDAD), Cholestatic jaundice, Hepatitis, Stevens-Johnson Syndrome (SJS), Anaphylaxis, Hemolytic anemia. ### Key Drug Interactions - **Warfarin**: May **increase INR**. Monitor INR closely; adjust warfarin dose if needed. - **Methotrexate**: May **increase methotrexate levels**, leading to toxicity. Avoid co-administration or monitor for toxicity. - **Allopurinol**: Concurrent use significantly **increases risk of skin rash**. Avoid co-administration. - **Oral Contraceptives**: May reduce efficacy of oral contraceptives. Advise alternative birth control methods. ## Monitoring & Follow-up - **Before Treatment**: Assess for penicillin allergy history, baseline renal and hepatic function (if risk factors present). - **During Treatment**: - Monitor for signs of **allergic reaction** (rash, itching, difficulty breathing). - Monitor for **diarrhea** (can indicate C. diff). - Monitor **liver function tests** (LFTs) if treatment is prolonged or in patients with pre-existing hepatic impairment. - Monitor **renal function** if pre-existing impairment or prolonged use. - **Clinical Signs**: Watch for persistent fever, worsening symptoms, or new onset of adverse effects. ## Clinical Pearls - 💡 **Tip 1**: Administer with a **meal or snack** to enhance absorption and reduce GI upset. - 💡 **Tip 2**: Complete the **entire prescribed course** of therapy, even if symptoms improve, to prevent resistance. - 💡 **Tip 3**: Oral suspensions **must be refrigerated** after reconstitution and discarded after 10 days. Shake well before each use. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.